184 related articles for article (PubMed ID: 35145399)
1. Caffeine Therapy for Apnea of Prematurity: Role of the Circadian
Guo HL; Long JY; Hu YH; Liu Y; He X; Li L; Xia Y; Ding XS; Chen F; Xu J; Cheng R
Front Pharmacol; 2021; 12():724145. PubMed ID: 35145399
[TBL] [Abstract][Full Text] [Related]
2. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
[TBL] [Abstract][Full Text] [Related]
3. Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up.
Dai HR; Guo HL; Hu YH; Xu J; Ding XS; Cheng R; Chen F
Front Pharmacol; 2022; 13():1053210. PubMed ID: 36532766
[TBL] [Abstract][Full Text] [Related]
4. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].
Xie JB; Lin XZ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):832-837. PubMed ID: 35894202
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms.
Dai HR; Liu Y; Lu KY; He X; Guo HL; Hu YH; Xu J; Ding XS; Chen F; Cheng R; Jiao Z
Pharmacol Res; 2022 Oct; 184():106416. PubMed ID: 36029933
[TBL] [Abstract][Full Text] [Related]
6. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
7. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
[TBL] [Abstract][Full Text] [Related]
8. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
10. Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
Rosen C; Taran C; Hanna M; Gueta I; Loebstein R; Strauss T; Yarden-Bilavsky H
J Perinatol; 2021 Sep; 41(9):2292-2297. PubMed ID: 34290376
[TBL] [Abstract][Full Text] [Related]
11. Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study.
Kumar M; Ali A; Khan MA; Sohail S; Saleem SM; Khan M; Naz F; Khan WA; Salat MS; Hussain K; Ambreen G
BMC Pediatr; 2022 Jul; 22(1):437. PubMed ID: 35864501
[TBL] [Abstract][Full Text] [Related]
12. Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol.
Irimu G; Okwaro F; Coleman J; Waiyego M; Murila F; Chomba D; Parsimei M; Shitote C; Ochieng R; Shah J; Ogero M; Ginsburg AS; Ansermino JM; Macharia W
Implement Sci Commun; 2023 Jul; 4(1):80. PubMed ID: 37461120
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H
Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821
[TBL] [Abstract][Full Text] [Related]
14. [Apnea of prematurity - characteristic and treatment].
Goryniak A; Szczęśniak A; Śleboda D; Dołęgowska B
Postepy Biochem; 2017; 63(2):151-154. PubMed ID: 28689383
[TBL] [Abstract][Full Text] [Related]
15. Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors.
Long JY; Guo HL; He X; Hu YH; Xia Y; Cheng R; Ding XS; Chen F; Xu J
Front Pharmacol; 2021; 12():681842. PubMed ID: 34381359
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
[TBL] [Abstract][Full Text] [Related]
17. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the aryl hydrocarbon receptor-signaling pathway and sleep disturbances in middle-aged women.
Ziv-Gal A; Flaws JA; Mahoney MM; Miller SR; Zacur HA; Gallicchio L
Sleep Med; 2013 Sep; 14(9):883-7. PubMed ID: 23768840
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study.
Fan Z; Hou L; Wan D; Ao R; Zhao D; Yu S
J Headache Pain; 2018 Jan; 19(1):1. PubMed ID: 29318394
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
